Patients with double/triple copy number gains on C-MYC, BCL2, and/or BCL6 treated with standard chemotherapy have a similarly poor prognosis than those with high-grade B cell lymph...

por Willenbacher, Ella, Willenbacher, Wolfgang, Weger, Roman, Dominik, Wolf, Manzl, Claudia, Brunner, Andrea
Publicado 2020